Programme Overview

Friday 02 October 2026
18:00 – 19:00 Registration Opens
19:00 – 19:05 Welcome: Prof Vernon Louw
19:05 – 20:15 SYMPOSIUM: CLL Sponsored by Astra Zeneca 
Chair:  Prof Vernon Louw  
Topic: Bridging evidence and practice: BTK inhibition in CLL
Speaker: tbc
Case Study :  
Q&A
20:15 – 22:00 Canapes and Conversation
Saturday 03 October 2026
07:00 Registration & Exhibition Opens
08:00 – 08:05 Conference Opening : Prof Vernon Louw Nurses Session
08:10 – 09:10 SYMPOSIUM: CLL Sponsored by  BeOne
Chair:
Evolving strategies in CLL: Optimizing care for long-term outcomes
Speaker :  Dr Talha Munir
Q&A
09:10 – 09:25 Standing on the Shoulders of Giants
09:25 – 09:30 “100 in 10 programme”
09:30 – 10:30 Session 1: Multiple Myeloma
  Chair:
09:30 – 10:05 Topic:  Transplant Ineligible Multiple Myeloma
Speaker :  Prof M Mohty (sponsored by J&J)
10:05 – 10:15 Case Study
10:15 – 10:30 Q & A
10:30 – 10:50 Refreshment Break
10:50 – 12:00 Session 2: Image Matters
  Chair: 
10:50 – 11:20 Topic: The evolving role of Nuclear Medicine in Haematological Malignancies
Speaker: Prof Bawinile Hadebe
11:20 – 11:50 Topic: The intersection of Interventional Radiology and the Bleeding patient
Speaker: Dr Gary Sudwartz
11:50 – 12:00 Panel Discussion and Q & A
12:00 – 12:10 Campaigning for Cancer – call to Action
12:10 – 13:00 Lunch
13:00 – 14:05 Session 3: Mantle Cell Lymphoma
  Chair: tbc
13:00 – 13:20 Topic: Pathology updates in MCL
Speaker: Dr Tomek Piorkowski (Sponsored by Pathcare)
13:20 – 13:50 Topic: Advances in the management of MCL
Speaker: Prof Talha Munir (Sponsored by BeOne)
Panel discussion and Q&A
13:50 – 14:05 Panel discussion and Q&A
14:05 – 15:00
 
Session 4: ALL
  Chair:  Dr David Brittain
14:05 – 14:40 Topic: Updates in ALL –  from clinical guidelines to MRD guided treatment and an inevitable immunotherapy revolution?
Speaker: Dr Perry Loebenberg
14:40 – 15:00 Panel discussion and Q+A
15:00 – 15:30 Refreshment Break
15:30 – 16:30 Session 5: Oral Presentations 
Chairs: Dr Karen Gunther
Oral Presentations  
16:30 – 16:35 Poster Gallery briefing
16:35 – 17:00 Poster session
17:00 – 18:00 SACHAS AGM
19:00 – 23:30 Conference Dinner
Sunday 04 September 2026
08:00 – 09:00 SYMPOSIUM : Bleeding disorders – Haemophilia and beyond Sponsored by NovoNordisk 
Chair: Prof Jaco Joubert  
Topic: Factors – more than you think…
Speaker :  to be confirmed? 
Q&A
09:00 – 10:00 Session 6: CML  
  Chair:
09:00 – 09:30 Topic:  Beyond Survival: Shared decisions, better lives in CML
Speaker:  Prof Vernon Louw (Sponsored by Novartis) 
 
09:30 – 09:45 Case study/Patient advocate? 
 
09:45 – 10:00 Panel discussion and Q&A  
 
10:00 – 10:30 Refreshment Break
10:30 – 11:30 Session 7: Patient Blood Management  
  
  
Chair: Prof Vernon Louw
10:30 – 10:50 Topic 1: Improved diagnosis of Iron Deficiency Anaemia in the Critically Ill via Fluorescence Flowcytometric Haemoglobin Biomarkers
Speaker: Christian Hönemann 
10:50 – 11:10 Topic 2: Exploring new Cellular Biomarkers from routine blood count using Fluorescence Flowcytometric parameters: The potential of The Intensive Care Infection Score.
Speaker: Christian Hönemann 
11:10 – 11:20 Q&A 
11:20 – 12:20 Session 9: Ethics  
  Chair: 
11:20 – 12:00 Topic: AI  
  Speaker : Prof Jacques Malherbe 
12:00 – 12:15 Q&A 
12:15 – 12:30 Conference Closing 
Prof Vernon Louw
12:30 Light lunch  

About AstraZeneca

AstraZeneca is a science-led, patient-focused biopharmaceutical company committed to transforming healthcare and improving outcomes. We believe science, powered by digital, data and AI, is key to addressing the world’s most pressing healthcare challenges.

We strive to improve access to life-changing medicines and pioneering solutions, while also supporting earlier detection, integrated care pathways, and stronger health systems so more people can receive the right care at the right time. Powered by scientific innovation, and increasingly enabled by digital, data and AI, we are helping redefine cancer care, improve outcomes in chronic diseases, and expand access to care in a sustainable and responsible way.

Activity ID: ZA-6886; Expiry date: 30 June 2028

https://www.astrazeneca.com/country-sites/african-cluster.html

About Novo Nordisk

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built on our heritage in diabetes. Through scientific innovation, expanded access to medicines, and partnerships across healthcare and technology, we help bring meaningful solutions to patients worldwide. Novo Nordisk employs about 67,900 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 304 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter, Instagram and YouTube.

Loading...